Skip to main content

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients

Journal of Neuro-Oncology volume 88, pages 97–103 (2008)Cite this article

Abstract

Objectives The optimal treatment for elderly patients (age > 70 years) with glioblastoma remains controversial. We conducted a prospective trial in 32 consecutive elderly patients with glioblastoma who underwent surgery followed by radiotherapy (RT) plus concomitant and adjuvant temozolomide. Patients and Methods 32 patients 70 years of age or older with a newly diagnosed glioblastoma and a Karnofsky performance status (KPS) ≥ 70 were treated with RT (daily fractions of 2 Gy for a total of 60 Gy) plus temozolomide at the dose of 75 mg/m2 per day followed by six cycles of adjuvant temozolomide (150–200 mg/m2 for 5 days during each 28-day cycle). The primary endpoint was overall survival (OS). Secondary endpoints included progression free survival (PFS) and toxicity. Results The median OS was 10.6 months and the median PFS was 7 months. The 6-month and 12-month survival rates were 91% and 37%, respectively. The 6-month and 12-month PFS rates were 56% and 16%, respectively. In multivariate analysis KPS was the only significant independent predictive factor of survival (P = 0.01). Adverse effects were mainly represented by neurotoxicity (40%), which resolved in most cases with the use of steroids, and Grade 3–4 hematologic toxicity in 28% of patients. Chemotherapy was stopped in 2 patients, delayed in 9 patients and reduced in 4 patients. Conclusions Standard RT plus concomitant and adjuvant temozolomide is a feasible treatment for elderly patients with newly diagnosed glioblastoma who present with good prognostic factors.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2

References

  1. Fleury A, Menegoz F, Grosclaude P et al (1997) Descriptive epidemiology of cerebral gliomas in France. Cancer 79:1195–2202

    PubMed  Article  CAS  Google Scholar 

  2. Chakrabarti I, Cockburn M, Cozen W et al (2005) A population-based description of glioblastoma multiforme in Los Angeles County, 1974–1999. Cancer 104:2798–806

    PubMed  Article  Google Scholar 

  3. Curran WJ Jr, Scott CB, Horton J et al (1993) Recursive partition analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 85:704–710

    PubMed  Article  Google Scholar 

  4. Meckling S, Dold O, Forsyth PA et al (1996) Malignat supratentorial glioma in the elderly: is radiotherapy useful? Neurology 47:901–905

    PubMed  CAS  Google Scholar 

  5. Shih Ha, Betensky RA, Dorfman MV et al (2005) Genetic analyses for predictors of radiation response in glioblastoma. Int J Radiat Oncol Biol Phys 63:704–711

    PubMed  CAS  Google Scholar 

  6. Batchelor TT, Betensky RA, Esposito JM et al (2004) Age-dependent prognostic effects of genetic alterations in glioblastoma. Clin Cancer Res 10:228–233

    PubMed  Article  CAS  Google Scholar 

  7. Minniti G, Brada M, Kleihues P, Ohgaki H (2006) Gliomas. In: Gospodarowicz MK, O’Sullivan B, Sobin LH (eds) Prognostic factors in cancer, 3rd edn, Wiley J &Sons, Hoboken, New Jersey

    Google Scholar 

  8. Whittle IR, Denholm SW, Gregor A et al (1991) Management of patients aged over 60 years with supratentorial glioma: lessons from an audit. Surg Neurol 36:106–111

    PubMed  Article  CAS  Google Scholar 

  9. Bauman GS, Fisher BJ, Halperin EC et al (1994) A prospective study of short course RT in poor prognosis glioblastoma multiforme. Int J Radiat Oncol Biol Phys 29:835–839

    PubMed  CAS  Google Scholar 

  10. Thomas R, James N, Guerrero D et al (1994) Hypofractionated radiotherapy as palliative treatment in poor prognosis patients with high grade glioma. Radiother Oncol 33:113–116

    PubMed  Article  CAS  Google Scholar 

  11. Ford JM, Stenning SP, Bootle DJ et al (1997) A short fractionation radiotherapy treatment for poor prognosis patients with high grade glioma. Clin Oncol (R Coll Radiol) 9:20–24

    CAS  Google Scholar 

  12. Hoegler DB, Davey P (1997) A prospective study of short course radiotherapy in elderly patients with malignant glioma. J Neurooncol 33(3):201–214

    PubMed  Article  CAS  Google Scholar 

  13. McAleese JJ, Stenning SP, Ashley S et al (2003) Hypofractionated radiotherapy for poor prognosis malignant glioma: matched pair survival analysis with MRC controls. Radiother Oncol 67:177–182

    PubMed  Article  CAS  Google Scholar 

  14. Roa W, Brasher PMA, Bauman G et al (2004) Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol 22:1593–1598

    Article  Google Scholar 

  15. Keime-Guiber F, Chinot O, Taillandier L et al (2007) Radiotherapy for glioblastoma in the elderly. N Engl J Med 356:1527–1535

    Article  Google Scholar 

  16. Glantz M, Chamberlain M, Liu Q et al (2003) Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas. Cancer 97:2262–2266

    PubMed  Article  CAS  Google Scholar 

  17. Chinot OL, Barrie M, Frauger E et al (2004) Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations. Cancer 100:2208–2214

    PubMed  Article  CAS  Google Scholar 

  18. Chamberlain MC, Chalmers L (2007) A pilot study of primary temozolomide chemotherapy and deferred radiotherapy in elderly patients with glioblastoma. J Neurooncol 82:207–209

    PubMed  Article  Google Scholar 

  19. Stupp R, Mason W, Van der Bent M et al (2005) Radiotherapy plus concomitant and adjuvant Temozolomide for glioblastoma. N Engl J Med 352:987–96

    PubMed  Article  CAS  Google Scholar 

  20. MacDonald DR, Cascino TL, Schold SC Jr et al (1990) Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8:1277–1280

    PubMed  CAS  Google Scholar 

  21. Mohan DS, Suh JH, Phan JL et al (1998) Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution. Int J Radiat Oncol Biol Phys 42:981–987

    PubMed  CAS  Google Scholar 

  22. Villà S, Vinolas N, Verger Eh et al (1998) Efficacy of radiotherapy for malignant gliomas in elderly patients. Int J Radiat Oncol Biol Phys 42:977–980

    PubMed  Google Scholar 

  23. Brandes AA, Vastola F, Basso U (2003) A prospective study in glioblastoma multiforme. Cancer 3:657–662

    Article  Google Scholar 

  24. Gilbert MR, Armstrong TS (1996) Glial neoplasms: classification, treatment, and pathways for the future. Oncol Nurs Forum 23:615–625

    PubMed  Google Scholar 

  25. Pierga JY, Hoang-Xuan K, Feuvret L et al (1999) Treatment of malignant gliomas in the elderly. J Neurooncol 43:187–193

    PubMed  Article  CAS  Google Scholar 

  26. Piccirilli M, Landi A, Salvati M et al (2006 ) Gliomatosis cerebri treatment in 11 elderly patients. J Exp Clin Cancer Res 25:183–187

    PubMed  CAS  Google Scholar 

  27. Mirimanoff RO, Gorlia T, Mason W et al (2006) Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial. Clin Oncol 24:2563–2569

    Article  CAS  Google Scholar 

  28. Hegi ME, Diserens AC, Gorlia T et al (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352:997–1003

    PubMed  Article  CAS  Google Scholar 

  29. De Sanctis V, Mazzarella G, Osti MF et al (2006) Radiotherapy and sequential temozolomide compared with radiotherapy with concomitant and sequential temozolomide in the treatment of newly diagnosed glioblastoma multiforme. Anticancer Drugs 17:969–975

    PubMed  Article  CAS  Google Scholar 

  30. Green H, Paul M, Vidal L et al (2007) Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials. Mayo Clin Proc 82:1052–1059

    PubMed  CAS  Article  Google Scholar 

  31. Lanzetta G, Campanella C, Rozzi A et al (2003) Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial. Anticancer Res 23:5159–5164

    PubMed  CAS  Google Scholar 

  32. Aiken RD (1994) Quality-of-life issues in patients with malignant gliomas. Semin Oncol 21:273–275

    PubMed  CAS  Google Scholar 

Download references

Author information

Affiliations

  1. Department of Radiotherapy Oncology, S Andrea Hospital, University “La Sapienza”, Via di Grottarossa 1035, 00189, Rome, Italy

    G. Minniti, V. De Sanctis, R. Muni, F. Filippone, M. Valeriani, M. F. Osti & R. Maurizi Enrici

  2. Department of Neurological Sciences, Neuromed Institute, Pozzilli, IS, Italy

    G. Minniti & G. Lanzetta

  3. Department of Neuroradiology, S Andrea Hospital, University “La Sapienza”, Via di Grottarossa 1035, 00189, Rome, Italy

    A. Bozzao

  4. Radiotherapy Oncology Unit, San Pietro Hospital, Rome, Italy

    U. De Paula

  5. Department of Radiotherapy Oncology, University Hospital of L’Aquila, L’Aquila, Italy

    V. Tombolini

Authors
  1. G. Minniti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. De Sanctis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Muni
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F. Filippone
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Bozzao
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Valeriani
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. F. Osti
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. U. De Paula
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. G. Lanzetta
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. V. Tombolini
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. R. Maurizi Enrici
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G. Minniti.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Minniti, G., De Sanctis, V., Muni, R. et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients. J Neurooncol 88, 97–103 (2008). https://doi.org/10.1007/s11060-008-9538-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-008-9538-0

Keywords

  • Glioblastoma
  • Elderly
  • Radiotherapy
  • Temozolomide